We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+7.5%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$417M
AUM Growth
+$15.8M
Cap. Flow
-$10.8M
Cap. Flow %
-2.59%
Top 10 Hldgs %
76.49%
Holding
76
New
2
Increased
13
Reduced
41
Closed
8

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.71M
2
GSK icon
GSK
GSK
+$1.94M
3
KMI icon
Kinder Morgan
KMI
+$622K
4
PFE icon
Pfizer
PFE
+$402K
5
VIVO
Meridian Bioscience Inc
VIVO
+$348K

Top Sells

Rank Stock Value
1
USB icon
US Bancorp
USB
+$3.68M
2
LNKD
LinkedIn Corporation
LNKD
+$3.09M
3
PSX icon
Phillips 66
PSX
+$1.9M
4
JOY
Joy Global Inc
JOY
+$1.2M
5
BHI
Baker Hughes
BHI
+$1.17M

Sector Composition

Rank Sector Weight
1 Financials 38.77%
2 Energy 17.96%
3 Healthcare 11.17%
4 Technology 9.5%
5 Consumer Discretionary 7.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.08T
$123M 29.61%
757,218
-695
-0.1% -$107K
XOM icon
2
ExxonMobil
XOM
$658B
$34.9M 8.37%
386,360
-3,765
-1% -$329K
IBM icon
3
IBM
IBM
$217B
$31.4M 7.53%
197,783
+2,191
+1% +$334K
USG
4
DELISTED
Usg
USG
$27.2M 6.52%
941,660
-6,180
-0.7% -$170K
TPR icon
5
Tapestry
TPR
$26B
$25.6M 6.14%
730,570
-8,680
-1% -$317K
BP icon
6
BP
BP
$110B
$17M 4.09%
532,067
-1,645
-0.3% -$49.5K
WFC icon
7
Wells Fargo
WFC
$258B
$16.9M 4.07%
307,539
-5,950
-2% -$299K
MRK icon
8
Merck
MRK
$379B
$16.8M 4.04%
299,734
-3,815
-1% -$223K
JNJ icon
9
Johnson & Johnson
JNJ
$652B
$15.2M 3.65%
132,217
-1,650
-1% -$191K
KO icon
10
Coca-Cola
KO
$390B
$10.3M 2.47%
248,420
-4,695
-2% -$195K
BAC icon
11
Bank of America
BAC
$436B
$9.96M 2.39%
450,820
-2,550
-0.6% -$49.1K
USB icon
12
US Bancorp
USB
$98.3B
$7.76M 1.86%
151,085
-77,400
-34% -$3.68M
COP icon
13
ConocoPhillips
COP
$159B
$6.83M 1.64%
136,160
-17,305
-11% -$798K
JOY
14
DELISTED
Joy Global Inc
JOY
$4.87M 1.17%
173,845
-43,005
-20% -$1.2M
HD icon
15
Home Depot
HD
$336B
$4.62M 1.11%
34,474
-1,325
-4% -$171K
GSK icon
16
GSK
GSK
$103B
$4.02M 0.96%
83,512
+39,224
+89% +$1.94M
CSCO icon
17
Cisco
CSCO
$440B
$3.58M 0.86%
118,610
-3,775
-3% -$115K
TEVA icon
18
Teva Pharmaceuticals
TEVA
$43.6B
$3.37M 0.81%
+92,855
New +$3.71M
PEP icon
19
PepsiCo
PEP
$194B
$3.22M 0.77%
30,745
-175
-0.6% -$18.3K
WMT icon
20
Walmart Inc
WMT
$832B
$3.02M 0.73%
131,220
+8,175
+7% +$191K
NOV icon
21
NOV
NOV
$7.15B
$2.86M 0.69%
76,480
-1,400
-2% -$51K
SU icon
22
Suncor Energy
SU
$77.5B
$2.66M 0.64%
81,295
-12,750
-14% -$391K
CEF icon
23
Sprott Physical Gold and Silver Trust
CEF
$8.22B
$2.6M 0.62%
230,225
+1,100
+0.5% +$13.8K
RDS.A
24
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$2.4M 0.57%
45,618
-518
-1% -$25.8K
CHK
25
DELISTED
Chesapeake Energy Corporation
CHK
$2.1M 0.5%
1,493
-16
-1% -$20.9K
1
2 3 4

Similar funds

MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
PRC
Pearl River Capital Niles, Michigan $630M AUM 17.08% 1-Year Est. Return
SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
JWM
Janiczek Wealth Management Denver, Colorado $477M AUM 15.17% 1-Year Est. Return
TWM
TMD Wealth Management Scottsdale, Arizona $456M AUM 11.92% 1-Year Est. Return

Greylin Investment Management's Q4 2016 Portfolio in Review

As of Q4 2016, Greylin Investment Management held 76 positions worth $417M, up 4% from $401M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Greylin Investment Management's Q4 2016 filing shows 2 new, 13 increased, 41 reduced and 8 closed positions. Its largest new stake was Teva Pharmaceuticals: 92,855 shares worth $3.37M. The largest sale was US Bancorp, an estimated $3.68M.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 36% a quarter earlier, followed by Energy and Healthcare.

  • Greylin Investment Management's largest Q4 2016 buy was Teva Pharmaceuticals: 92,855 shares worth $3.37M.
  • Greylin Investment Management added most to GSK in Q4 2016, an estimated $1.94M increase.
  • Greylin Investment Management's biggest Q4 2016 reduction was US Bancorp, cutting an estimated $3.68M.
  • Greylin Investment Management fully exited LinkedIn Corporation in Q4 2016, selling an estimated $3.09M.
  • Greylin Investment Management's ten largest holdings make up 76% of its $417M portfolio in Q4 2016.
  • Greylin Investment Management opened 2 new positions and closed 8 in Q4 2016.
  • Greylin Investment Management's portfolio value rose 4% quarter-over-quarter to $417M.

Based on Greylin Investment Management's 13F filing for Q4 2016, filed 18 Jan 2017.